MAVS and viral infectious disease: It was suggested that residual RIG-I/MDA5-MAVS pathway-mediated I-IFN production might compensate for the lack of TLR3-IFN response during peripheral viral infections, accounting for the absence of a prior history of severe viral infections in these four patients (14, 15).